Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms

Sponsor
Case Comprehensive Cancer Center (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05225038
Collaborator
(none)
100
1
2
29.6
3.4

Study Details

Study Description

Brief Summary

Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise
  • Dietary Supplement: Nutritional
  • Behavioral: Behavioral Medicine
  • Behavioral: Smoking Cessation
N/A

Detailed Description

Frailty is independently associated with an increased risk of adverse outcomes after major surgery, including pancreatic resection. Prehabilitation aims to optimize modifiable risk factors to improve participants' baseline health prior to surgery. Multiple studies with participants undergoing pancreatic surgery have investigated the impact of prehabilitation on preoperative health metrics as well as postoperative outcomes. The majority of these studies focused only on exercise; if nutritional and/or psychological status were assessed, these dimensions were not intervened upon in prehabilitation regimens or reassessed postoperatively. This randomized controlled trial (RCT) is designed to assess the impact of physical and nutritional prehabilitation on participants' perioperative condition for those undergoing pancreatic resection for diagnosed or suspected pancreatic and periampullary neoplasms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for Patients With Pancreatic and Periampullary Neoplasms
Actual Study Start Date :
Jun 13, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Arm (Standard of Care)

Participants will receive the current standard preoperative education and counseling. Participants will receive information regarding exercise and nutrition from a member of the surgical team. Participants will meet with a behavioral medicine specialist for additional education regarding factors affecting postoperative stress and relaxation techniques. Participants who are actively smoking will be counseled regarding smoking cessation and offered a referral to smoking cessation resources.

Behavioral: Behavioral Medicine
Participants will have 1 appointment with behavioral medicine - all participants will meet with the same behavioral medicine specialist to ensure consistency. Participants will receive education regarding factors that affect postoperative recovery and relaxation techniques. Participants will also have the option to request faith support.

Behavioral: Smoking Cessation
Participants who are actively smoking will be counseled regarding smoking cessation during their preoperative appointment with a member of the surgical team. They will also be offered a referral to smoking cessation resources.

Experimental: Intervention Arm (Prehabilitation)

Participants in the intervention arm will receive all of the standard of care, as listed above, as well as individualized exercise and nutritional prehabilitation regimens. During the data analysis, participants will be subdivided into treatment groups, upfront surgical resection versus neoadjuvant chemotherapy, in order to determine whether length of prehabilitation affected outcomes and distinguish any possible effect of chemotherapy toxicity.

Other: Exercise
Participants will meet with an exercise physiologist to undergo evaluation and develop individualized regimens for prehabilitation.

Dietary Supplement: Nutritional
Participants will meet with a nutritionist to undergo evaluation and develop individualized regimens for prehabilitation.

Behavioral: Behavioral Medicine
Participants will have 1 appointment with behavioral medicine - all participants will meet with the same behavioral medicine specialist to ensure consistency. Participants will receive education regarding factors that affect postoperative recovery and relaxation techniques. Participants will also have the option to request faith support.

Behavioral: Smoking Cessation
Participants who are actively smoking will be counseled regarding smoking cessation during their preoperative appointment with a member of the surgical team. They will also be offered a referral to smoking cessation resources.

Outcome Measures

Primary Outcome Measures

  1. Change in participants physical capacity, as represented by hand grip strength [3 weeks after the surgery]

    Previous studies have demonstrated that grip strength is a predictor of surgical outcomes and mortality in cancer participants. Grip strength will be measured utilizing the Jamar Dynamometer.

Secondary Outcome Measures

  1. Mortality Rate [Up to 90 days after the surgery]

    Death due to any cause postoperatively.

  2. Morbidity rate [Up to 90 days after the surgery]

    Classified according to the Clavien-Dindo Classification of postoperative complications.

  3. Physical capacity as represented by 30s CST (Chair Stand Test ) [3 weeks after the surgery]

    Participants rise to full standing position from sitting in a chair as many times as possible within 30 seconds. The 30s CST has been utilized as a reliable test of lower extremity strength.

  4. Physical capacity as represented by 6-Minute Walk Test [3 weeks after the surgery]

    Participants will walk as far as possible in 6 min at a comfortable pace but do not run or jog. If participants cannot complete the full 6 min walk, then record the time and distance walked and the reason for stopping early.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants > 18 years old with ECOG performance status 0-2 and ASA score ≤3

  • Requiring pancreatic resection for diagnosed or suspected pancreatic and periampullary neoplasms

  • Surgery scheduled at least 2 weeks after the initial surgical evaluation

  • Fluency in English

  • Willingness to answer questionnaires, complete daily exercise & nutrition log, as well as participate in follow-up telephone calls

  • Screening: Physical Activity Readiness - Questionnaire (PAR-Q+)

  • PAR-Q+ assesses participants comorbidities and symptoms with current activities. If participants answer "yes" to any of the screening questions, they will need to complete additional questions regarding their chronic medical conditions including, but not limited to, heart disease, stroke, diabetes, depression/anxiety, and COPD/asthma, to determine their ability to participate in physical activity.

Exclusion Criteria:
  • Screening: Physical Activity Readiness - Questionnaire (PAR-Q+)

  • Participants with concurrent medical conditions that prohibit exercise, such as those who indicate on the questionnaire that they experience chest pain, dizziness, or loss of consciousness with physical activity; those with chest pain at rest; or those with bone/joint/soft tissue conditions that could worsen with physical activity. Participants with specific comorbidities, such as coronary artery disease. congestive heart failure, or uncontrolled asthma/COPD, that may prevent participation will also be excluded.

  • Inability to provide own informed consent

  • Inability to read or verbally understand questionnaires in English

  • Impaired hearing that creates a barrier for telephone follow-up

  • Visual deficit that would cause exercise to be hazardous

  • Emergent or urgent surgeries

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Cleveland Ohio United States 44195

Sponsors and Collaborators

  • Case Comprehensive Cancer Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT05225038
Other Study ID Numbers:
  • CASE8221
First Posted:
Feb 4, 2022
Last Update Posted:
Aug 5, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2022